Evaluating the Correlation Between Migraine and Subclinical Atherosclerosis Publisher Pubmed



Esmaeili S^{1, 2, 3} ; Alizadeh M⁴ ; Abdi Y³ ; Allahdadian S⁵ ; Chaibakhsh S⁶ ; Naderkhani M^{7, 8} ; Farzad Maroufi S⁹ ; Baharvand F³ ; Mirzaasgari Z³ ; Taghi Joghataei M^{1, 2} Show Affiliations
Source: Journal of Clinical Neuroscience Published:2022

Abstract

Backgrounds and aims: Migraine is known to be associated with vascular dysfunction. However, sufficient evidence has not been reported in this regard. This study aims to assess subclinical atherosclerosis and endothelial function via Doppler Sonography in migraine patients. Methods: In this case control study, Subjects were divided into two groups; Patients with migraine, and Healthy controls. Migraine was diagnosed according to the International Classification of Headache Disorders criteria. Participants were evaluated for carotid intima-media thickness (IMT) and flow-mediated dilation (FMD) indices, and the findings were compared between the two groups. Results: In the study population, 64.9 % were female, and the mean age was 34.63 ± 6.06 years. Of the 47 people with migraine, 12 suffered from migraine with aura. Increased IMT was more in migraine with and without aura compared to control (p = 0.247), and FMD was lower in these groups than the control group (p = 0.311). There was a significant correlation between the duration of headache with the duration of migraine (p = 0.007, 0.389) and IMT (p = 0.038, 0.303). No statistically significant differences were observed between NSAID, acetaminophen, and ergotamine groups with IMT (p = 0.532) and FMD (p = 0.834). Conclusion: Migraine and its related medications do not affect vascular changes in favor of atherosclerosis. However, these findings might be valid for patients with acute migraines only. © 2022 Elsevier Ltd